LEGISLATIVE SERVICES AGENCY
OFFICE OF FISCAL AND MANAGEMENT ANALYSIS
200 W. Washington St., Suite 301
Indianapolis, IN 46204
(317) 233-0696
iga.in.gov
FISCAL IMPACT STATEMENT
LS 6885 NOTE PREPARED: Mar 11, 2021
BILL NUMBER: HB 1109 BILL AMENDED: Feb 8, 2021
SUBJECT: INSPECT Program Reporting.
FIRST AUTHOR: Rep. Bartels BILL STATUS: Enrolled
FIRST SPONSOR: Sen. Charbonneau
FUNDS AFFECTED: GENERAL IMPACT: No Fiscal Impact
DEDICATED
FEDERAL
Summary of Legislation: This bill provides that a dispenser who is also authorized to prescribe ephedrine,
pseudoephedrine, or a controlled substance is required only to report to the Indiana Scheduled Prescription
Electronic Collection and Tracking (INSPECT) program actual dispensations within 24 hours of the
dispensation.
Effective Date: July 1, 2021.
Explanation of State Expenditures: The bill adds clarifying language regarding the duty of dispensers with
prescribing authority to report dispensations to INSPECT, but does not change the reporting requirements
for these dispensers. Therefore, the Board of Pharmacy and Professional Licensing Agency are not expected
to experience a fiscal impact from this provision.
Explanation of State Revenues:
Explanation of Local Expenditures:
Explanation of Local Revenues:
State Agencies Affected:
Local Agencies Affected:
Information Sources:
HB 1109 1
Fiscal Analyst: Adam White, 317-234-1360.
HB 1109 2


Statutes affected:
1. Introduced House Bill (H): 25-1-9.3-6, 25-26-24-12
2. House Bill (H): 25-26-24-17
3. House Bill (S): 25-26-24-17
4. Enrolled House Bill (H): 25-26-24-17